Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer
Sara Moreno-SanJuan, Jose D. Puentes-Pardo, Jorge Casado, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 926-926
Open Access | Times Cited: 11

Showing 11 citing articles:

Melatonin in cancer biology: pathways, derivatives, and the promise of targeted delivery
Yu-juan Yi, Hong Tang, Peng-lai Pi, et al.
Drug Metabolism Reviews (2024) Vol. 56, Iss. 1, pp. 62-79
Closed Access | Times Cited: 7
Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer
Carlos Martínez‐Campa, Virginia Álvarez-García, Carolina Alonso‐González, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 956-956
Open Access | Times Cited: 7
Development of novel triconjugates fusing melatonin/isatin/N-acylhydrazone targeting colorectal cancer: design, synthesis, biological, and in silico ADME/Tox profiling
Sergio Gutiérrez, Wilson Cardona‐G, Angie Herrera‐Ramírez, et al.
Medicinal Chemistry Research (2025)
Closed Access
DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review
Xin Fu, Zhaosong Wang
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Neuropharmacologic modulation of the melatonergic system
Utku Aykan, Muhammed Cihan Güvel, Gökçen Paykal, et al.
Exploration of neuroscience (2023) Vol. 2, Iss. 6, pp. 287-306
Open Access | Times Cited: 7
The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy
Haodong Zhu, Jiawei Chen, Zeqin Wen, et al.
Life Sciences (2023) Vol. 333, pp. 122145-122145
Open Access | Times Cited: 5
The Circadian Clock as a Potential Biomarker and Therapeutic Target in Gastrointestinal Cancers
Sama Barati, Homina Saffar, Shima Mehrabadi, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 23, pp. 1804-1811
Closed Access
Novel monastrol/melatonin hybrids as a new approach for colorectal cancer intervention: design, synthesis, biological activity, and drug-likeness modeling studies
David Preciado-A, A.F. Yepes, Angie Herrera-R, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 9, pp. 1511-1525
Open Access
A potent therapeutic scaffold fusing quinazolinone/melatonin for future colorectal cancer interventions: design, one-pot synthesis, biological and ADME-tox modeling studies
David Preciado, Wilson Cardona‐G, Angie Herrera‐Ramírez, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 9, pp. 1698-1713
Open Access
Synergistic effects of cetuximab and agomelatine on gene expression in colon cancer cells
Rukiye Köse, Hilal Üstündağ, Elif Erbaş, et al.
Journal of Advances in VetBio Science and Techniques (2024)
Open Access
Agomelatine protects hippocampal neurons against doxorubicin induced toxicity
Betül Danışman, Betül Çiçek
GSC Biological and Pharmaceutical Sciences (2023) Vol. 24, Iss. 2, pp. 290-296
Open Access
Page 1

Scroll to top